News from the College

  • Lee & Hebert-Dufresne Publish SARS-CoV-2 Transmission Model for School Opening
    November 20, 2020
    Can schools safely remain open or reopen during periods of significant community spread of COVID-19? According to predictions from a UVM model of SARS-CoV-2 transmission in the school setting, yes – if appropriate precautions are followed both in school and in the community.
  • Villanti, Copeland Named to List of World’s Most Influential Researchers
    November 19, 2020
    UVM faculty members Andrea Villanti, Ph.D., M.P.H., associate professor of psychiatry, and William Copeland, Ph.D., professor of psychiatry, have been named to a list of the world’s most influential researchers - the Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • Developing a COVID-19 Vaccine: Q&A with Beth Kirkpatrick, M.D.
    November 16, 2020
    An internationally recognized physician-scientist, Beth Kirkpatrick, M.D., has a decades-long history of leadership in the field of vaccine testing and development. In 2001, she launched the UVM Vaccine Testing Center (VTC), and since then, the VTC has grown to assume a prominent role in the development and evaluation of vaccines for globally important infectious diseases. The VTC has garnered support from the National Institutes of Health, the Bill & Melinda Gates Foundation, and the U.S. Department of Defense, among others. Kirkpatrick is also principal investigator and director of UVM’s Translational Global Infectious Disease Research Center of Biomedical Research Excellence and Chair of the Department of Microbiology and Molecular Genetics.
  • Weiss Receives ALA Grant to Study COVID-19 Lung Damage
    November 13, 2020
    University of Vermont Professor of Medicine Daniel Weiss, M.D., Ph.D., has been selected to receive one of the inaugural American Lung Association COVID-19 Action Initiative's COVID-19 and Respiratory Virus Research Award.
  • Research Excellence Highlighted at Fifth Annual Celebration
    November 5, 2020
    The Larner College of Medicine hosted the fifth annual "Dean's Celebration of Excellence in Research" on November 4 and 5. The two-day event highlighted the research being conducted by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • College Remembers Helen Moray Larner (1925--2020)
    November 4, 2020
    The Larner College of Medicine lost one of its most steadfast and consequential supporters with the passing of Helen Moray Larner, wife of the late Robert Larner, M.D., on November 2, 2020.
  • UVM and UVM Health Network Participate in Phase 3 COVID-19 Vaccine Trial
    October 27, 2020
    The University of Vermont Medical Center and Vaccine Testing Center at the University of Vermont’s Larner College of Medicine have been selected to take part in a Phase 3 trial for a COVID-19 vaccine developed by Oxford University and manufactured by AstraZeneca.
  • Study Finds Lowering Nicotine Reduces Smoking Addictiveness in Vulnerable Populations
    October 20, 2020
    A JAMA Network Open study, led by Stephen T. Higgins, Ph.D., director of the Vermont Center on Behavior and Health at the University of Vermont’s Larner College of Medicine, provides evidence that, even in smokers from vulnerable populations, reducing nicotine content to low levels decreases addictiveness – a timely finding as the Food and Drug Administration (FDA) considers a policy to lower nicotine content in all cigarettes sold in the U.S.
  • UVM Scientist Plays Lead Role in #BlackinCardio Campaign
    October 19, 2020
    Organized by Black physicians and scientists in the United States and abroad, the #BlackInCardio movement celebrates Black researchers, clinicians, and professionals in cardiovascular fields and raises awareness of cardiovascular diseases that disproportionately effect the Black community. From October 19 - October 25, the new organization will host its first annual #BlackInCardio week.
  • Diehl & Colleagues Uncover Critical Information about COVID-19 Immune Response
    October 15, 2020
    New research, published in Clinical and Translational Immunology by UVM Associate Professor Sean Diehl, Ph.D., and colleagues provides a clearer picture of the protective antibodies induced by the SARS-C0V-2 virus and their role in serious illness and what’s needed for full protection.